Common use of Authorization of Notes Clause in Contracts

Authorization of Notes. The Issuer will authorize the issue and sale of $240,000,000 aggregate principal of its Guaranteed Senior Notes, of which $120,000,000 aggregate principal amount shall be its 4.69% Series A Guaranteed Senior Notes due January 10, 2026 (the “Series A Notes”) and $120,000,000 aggregate principal amount shall be its 4.79% Series B Guaranteed Senior Notes due January 10, 2028 (the “Series B Notes”; the Series A Notes and the Series B Notes are hereinafter referred to collectively as the “Notes”). The Series A Notes and the Series B Notes shall be substantially in the forms set out in Schedule 1(a) and Schedule 1(b), respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A and, for purposes of this Agreement, the rules of construction set forth in Section 23.4 shall govern.

Authorization of Notes. The Issuer Company will authorize the issue and sale of $240,000,000 aggregate principal of its Guaranteed Senior Notes, of which $120,000,000 100,000,000 aggregate principal amount shall be of Senior Notes consisting of (a) $50,000,000 aggregate principal amount of its 4.695.09% Series A Guaranteed Senior Notes due January 10March 22, 2026 2029 (the “Series A Notes”) and (b) $120,000,000 50,000,000 aggregate principal amount shall be of its 4.795.17% Series B Guaranteed Senior Notes due January 10March 22, 2028 2029 (the “Series B Notes”; the ). The Series A Notes and the Series B Notes are hereinafter referred to collectively as the “Notes”). The Series A Notes and the Series B Notes shall be substantially in the forms set out in Schedule 1(a) and Schedule 1(b), respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A and, for purposes of this Agreement, the rules of construction set forth in Section 23.4 22.4 shall govern.

Authorization of Notes. The Issuer will authorize the issue and sale of $240,000,000 200,000,000 aggregate principal of its Guaranteed Senior Notes, of which $120,000,000 125,000,000 aggregate principal amount shall be its 4.694.30% Series A Guaranteed Senior Notes due January 10April 20, 2026 2027 (the “Series A Notes”) and $120,000,000 75,000,000 aggregate principal amount shall be its 4.794.40% Series B Guaranteed Senior Notes due January 10April 20, 2028 2029 (the “Series B Notes”; the Series A Notes and the Series B Notes are hereinafter referred to collectively as the “Notes”). The Series A Notes and the Series B Notes shall be substantially in the forms set out in Schedule 1(a) and Schedule 1(b), respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A and, for purposes of this Agreement, the rules of construction set forth in Section 23.4 shall govern.

Authorization of Notes. The Issuer will authorize the issue and sale of $240,000,000 300,000,000 aggregate principal amount of its Guaranteed Senior Notes, of which $120,000,000 100,000,000 aggregate principal amount shall be its 4.692.74% Series A F Guaranteed Senior Notes due January 10September 17, 2026 2030 (the “Series A F Notes”) and $120,000,000 200,000,000 aggregate principal amount shall be its 4.792.84% Series B G Guaranteed Senior Notes due January 10September 17, 2028 2032 (the “Series B G Notes”; the Series A F Notes and the Series B G Notes are hereinafter referred to collectively as the “Notes”). The Series A F Notes and the Series B G Notes shall be substantially in the forms set out in Schedule 1(a1(f) and Schedule 1(b1(g), respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A and, for purposes of this Agreement, the rules of construction set forth in Section 23.4 shall govern.

Authorization of Notes. The Issuer Obligors will authorize the issue and sale of (i) $240,000,000 75,000,000 aggregate principal amount of its Guaranteed their 5.18% Senior Notes, of which $120,000,000 aggregate principal amount shall be its 4.69% Series A Guaranteed Senior Notes D, due January February 10, 2026 2021 (the “Series A D Notes”) and (ii) $120,000,000 50,000,000 aggregate principal amount shall be its 4.79of their 5.49% Senior Notes, Series B Guaranteed Senior Notes E, due January February 10, 2028 2023 (the “Series B E Notes”; , together with the Series A Notes and the Series B Notes are hereinafter referred to collectively as D Notes, the “Notes”,” such term to include any such notes issued in substitution therefor pursuant to Section 13). The Series A Notes and the Series B D Notes shall be substantially in the forms form set out in Schedule Exhibit 1(a) and Schedule ). The Series E Notes shall be substantially in the form set out in Exhibit 1(b), respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A andB; and references to a “Schedule” or an “Exhibit” are, for purposes of unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement, the rules of construction set forth in Section 23.4 shall govern.

Authorization of Notes. The Issuer Company will authorize the issue and sale of (i) $240,000,000 25,000,000 aggregate principal amount of its Guaranteed 5.57% Senior Notes, of which $120,000,000 aggregate principal amount shall be its 4.69% Series A Guaranteed Senior Notes A, due January 10July 22, 2026 2028 (the “Series A Notes”); (ii) and $120,000,000 45,000,000 aggregate principal amount shall be of its 4.795.78% Senior Notes, Series B Guaranteed Senior Notes B, due January 10July 22, 2028 2030 (the “Series B Notes”; ) and (iii) $45,000,000 aggregate principal amount of its 6.09% Senior Notes, Series C, due July 22, 2032 (the “Series C Notes”, and together with the Series A Notes and the Series B Notes are hereinafter referred to collectively as Notes, the “Notes”). The Series A Notes and the Series B Notes shall be substantially in the forms set out in Schedule 1(a) Schedules 1- A, 1-B and Schedule 1(b)1-C, respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A and, for purposes of this Agreement, the rules of construction set forth in Section 23.4 22.4 shall govern. The Series A Notes, the Series B Notes and the Series C Notes are each herein sometimes referred to as Notes of a “series.”

Authorization of Notes. The Issuer will authorize the issue and sale of $240,000,000 150,000,000 aggregate principal of its Guaranteed Senior Notes, of which $120,000,000 75,000,000 aggregate principal amount shall be its 4.694.22% Series A Guaranteed Senior Notes due January 10August 31, 2026 2029 (the “Series A Notes”) and $120,000,000 75,000,000 aggregate principal amount shall be its 4.794.30% Series B Guaranteed Senior Notes due January 10August 31, 2028 2032 (the “Series B Notes”; the Series A Notes and the Series B Notes are hereinafter referred to collectively as the “Notes”). The Series A Notes and the Series B Notes shall be substantially in the forms set out in Schedule 1(a) and Schedule 1(b), respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A and, for purposes of this Agreement, the rules of construction set forth in Section 23.4 shall govern.

Authorization of Notes. The Issuer Company will authorize the issue and sale of $240,000,000 340,000,000 aggregate principal amount of its Guaranteed Senior Notes, of which $120,000,000 148,000,000 aggregate principal amount shall be its 4.694.35% Series A Guaranteed Senior Notes due January 10August 22, 2026 2024 (the “Series A Notes”) and $120,000,000 192,000,000 aggregate principal amount shall be its 4.794.56% Series B Guaranteed Senior Notes due January 10August 22, 2028 2026 (the “Series B Notes”; the Series A Notes and the Series B Notes are hereinafter referred to collectively as the “Notes”). The Series A Notes and the Series B Notes shall be substantially in the forms set out in Schedule 1(a) and Schedule 1(b), respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A and, for purposes of this Agreement, the rules of construction set forth in Section 23.4 22.4 shall govern.

Authorization of Notes. The Issuer Company will authorize the issue and sale of $500,000,000 aggregate principal amount of its Senior Secured Notes consisting of (a) $240,000,000 aggregate principal amount of its Guaranteed Senior Notes, of which $120,000,000 aggregate principal amount shall be its 4.695.15% Series A Guaranteed Senior Secured Notes due January 10September 5, 2026 2032 (the “Series A Notes”), (b) and $120,000,000 160,000,000 aggregate principal amount shall be of its 4.795.29% Series B Guaranteed Senior Secured Notes due January 10September 5, 2028 2034 (the “Series B Notes”; ) and (c) $100,000,000 aggregate principal amount of its 5.49% Series C Senior Secured Notes due September 5, 2037 (the “Series C Notes” and, together with the Series A Notes and the Series B Notes, as amended, restated or otherwise modified from time to time pursuant to Section 18 and including any such Notes are hereinafter referred issued in substitution therefor pursuant to collectively as Section 14, the “Notes”). The Notes of any Series A Notes and the Series B Notes shall be substantially in the forms form set out in Schedule 1(a) and Schedule 1(b), respectively1 with respect to such Series. Certain capitalized and other terms used in this Agreement are defined in Schedule A and, for purposes of this Agreement, the rules of construction set forth in Section 23.4 24.4 shall govern.

Authorization of Notes. The Issuer Company will authorize the issue and sale of (i) $240,000,000 aggregate principal of its Guaranteed Senior Notes, of which $120,000,000 50,000,000 aggregate principal amount shall be of its 4.694.57% Series A Guaranteed Senior Notes Unsecured Notes, Series A, due January 1024, 2026 2021 (the “Series A Notes”) and (ii) $120,000,000 50,000,000 aggregate principal amount shall be of its 4.795.20% Series B Guaranteed Senior Notes Unsecured Notes, Series B, due January 1024, 2028 2021 (the “Series B Notes”; ,” and together with the Series A Notes and the Series B Notes are hereinafter referred to collectively as Notes, collectively, the “Notes”,” such term to include any such notes issued in substitution therefor pursuant to Section 14). The Series A Notes and the Series B Notes shall be substantially in the forms form set out in Schedule 1(a) Exhibit 1-A and Schedule 1(b)1-B, respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A andB; references to a “Schedule” or an “Exhibit” are, for purposes of unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement, the rules of construction set forth in Section 23.4 shall govern.

Authorization of Notes. The Issuer will authorize the issue and sale of $240,000,000 300,000,000 aggregate principal of its Guaranteed Senior Notes, of which $120,000,000 150,000,000 aggregate principal amount shall be its 4.693.86% Series A C Guaranteed Senior Notes due January 10February 15, 2026 2028 (the “Series A C Notes”) and $120,000,000 150,000,000 aggregate principal amount shall be its 4.793.96% Series B D Guaranteed Senior Notes due January 10February 15, 2028 2030 (the “Series B D Notes”; the Series A C Notes and the Series B D Notes are hereinafter referred to collectively as the “Notes”). The Series A C Notes and the Series B D Notes shall be substantially in the forms set out in Schedule 1(a1(c) and Schedule 1(b1(d), respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A and, for purposes of this Agreement, the rules of construction set forth in Section 23.4 shall govern.

Authorization of Notes. The Issuer Company will authorize the issue and sale of $240,000,000 300,000,000 aggregate principal amount of its Guaranteed Senior Notes, of which $120,000,000 150,000,000 aggregate principal amount shall be its 4.692.46% Senior Notes, Series A Guaranteed Senior Notes A, due January 10May 25, 2026 2028 (the “Series A Notes”) and $120,000,000 150,000,000 aggregate principal amount shall be its 4.793.18% Senior Notes, Series B Guaranteed Senior Notes B, due January 10May 25, 2028 2036 (the “Series B Notes”; the ). The Series A Notes and the Series B Notes are hereinafter referred to collectively as the “Notes”). .” The Series A Notes and the Series B Notes shall be substantially in the forms set out in Schedule 1(a) and Schedule 1(b), respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A and, for purposes of this Agreement, the rules of construction set forth in Section 23.4 22.4 shall govern.

Authorization of Notes. The Issuer Company will authorize the issue and sale of (a) $240,000,000 15,000,000 aggregate principal amount of its Guaranteed 3.38% Senior Notes, of which $120,000,000 aggregate principal amount shall be its 4.69% Series A Guaranteed Senior Notes A, due January 10December 20, 2026 2020 (the “Series A Notes”), and (b) and $120,000,000 15,000,000 aggregate principal amount shall be of its 4.795.26% Senior Notes, Series B Guaranteed Senior Notes B, due January 10December 20, 2028 2040 (the “Series B Notes”; the Series A Notes and the Series B Notes are being hereinafter collectively referred to collectively as the “Notes”, such term to include any such notes issued in substitution therefor pursuant to Section 13). The Series A Notes and the Series B Notes shall be substantially in the forms form set out in Schedule 1(a) Exhibit 1-A and Schedule 1(b)1-B, respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A andB; and references to a “Schedule” or an “Exhibit” are, for purposes of unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement, the rules of construction set forth in Section 23.4 shall govern.

Authorization of Notes. The Issuer Company will authorize the issue and sale of (i) $240,000,000 70,000,000 aggregate principal amount of its Guaranteed 5.17% Senior Notes, of which $120,000,000 aggregate principal amount shall be its 4.69% Series A Guaranteed Senior Notes A, due January 10September 1, 2026 2039 (the “Series A Notes”) and (ii) $120,000,000 70,000,000 aggregate principal amount shall be of its 4.795.42% Senior Notes, Series B Guaranteed Senior Notes B, due January 10September 1, 2028 2053 (the “Series B Notes”; ” and, together with the Series A Notes and the Series B Notes are hereinafter referred to collectively as Notes, collectively, (the “Notes”,” such term to include any such notes issued in substitution therefor pursuant to Section 14). The Series A Notes shall be substantially in the form set out in Schedule 1(a) and the Series B Notes shall be substantially in the forms form set out in Schedule 1(a) and Schedule 1(b), respectively. Each series of Notes is sometimes referred to herein as a “series”. Certain capitalized and other terms used in this Agreement are defined in Schedule A and, for purposes of this Agreement, the rules of construction set forth in Section 23.4 22.4 shall govern.

Authorization of Notes. The Issuer will authorize the issue and sale of $240,000,000 €750,000,000 aggregate principal amount of its Guaranteed Senior Notesguaranteed senior notes, of which $120,000,000 (a) €400,000,000 aggregate principal amount shall be its 4.691.62% Series A D Guaranteed Senior Notes due January 107, 2026 2031 (the “Series A D Notes”) and $120,000,000 (b) €350,000,000 aggregate principal amount shall be its 4.791.65% Series B E Guaranteed Senior Notes due January 107, 2028 2033 (the “Series B E Notes”; the ). The Series A D Notes and the Series B E Notes are hereinafter referred to collectively as the “Notes”). .” The Series A D Notes and the Series B E Notes shall be substantially in the forms set out in Schedule 1(aSchedules 1(d) and Schedule 1(b1(e), respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A and, for purposes of this Agreement, the rules of construction set forth in Section 23.4 shall govern.

Authorization of Notes. The Issuer Company will authorize the issue and sale sale, in two series, of $240,000,000 €300,000,000 aggregate principal amount of its Guaranteed Senior Notessenior notes, of which $120,000,000 €125,000,000 aggregate principal amount shall be its 4.694.355% Series A Guaranteed Senior Notes due January 10, 2026 2013 (the “Series A Notes”) and $120,000,000 €175,000,000 aggregate principal amount shall be its 4.794.585% Series B Guaranteed Senior Notes due January 10, 2028 2016 (the “Series B Notes”; ” and, together with the Series A Notes and the Series B Notes are hereinafter referred to collectively as Notes, the “Notes”, such term to include any such notes issued in substitution therefor pursuant to Section 13). The Series A Notes and the Series B Notes shall be substantially in the forms form set out in Schedule 1(a) Exhibits 1-A and Schedule 1(b)1-B, respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A andB; and references to a “Schedule” or an “Exhibit” are, for purposes of unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement, the rules of construction set forth in Section 23.4 shall govern.

Authorization of Notes. The Issuer will authorize the issue and sale of $240,000,000 600,000,000 aggregate principal amount of its Guaranteed Senior Notesguaranteed senior notes, of which (a) $120,000,000 200,000,000 aggregate principal amount shall be its 4.694.68% Series A Guaranteed Senior Notes due January 108, 2026 (the “Series A Notes”), and (b) and $120,000,000 400,000,000 aggregate principal amount shall be its 4.794.86% Series B Guaranteed Senior Notes due January 108, 2028 2029 (the “Series B Notes”; the ). The Series A Notes and the Series B Notes are hereinafter referred to collectively as the “Notes”). .” The Series A Notes and the Series B Notes shall be substantially in the forms set out in Schedule Schedules 1(a) and Schedule 1(b), respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A and, for purposes of this Agreement, the rules of construction set forth in Section 23.4 shall govern.

Authorization of Notes. The Issuer Company will authorize the issue and sale of (i) $240,000,000 37,500,000 aggregate principal amount of its Guaranteed 6.41% Senior Notes, of which $120,000,000 aggregate principal amount shall be its 4.69% Series A Guaranteed Senior Notes A, due January 10June 15, 2026 2013 (the “Series A Notes”") and (ii) $120,000,000 37,500,000 aggregate principal amount shall be of its 4.796.55% Senior Notes, Series B Guaranteed Senior Notes B, due January 10June 15, 2028 2016 (the “Series B Notes”; the Series A Notes and the Series B Notes are hereinafter collectively referred to collectively as the “Notes”", such term to include any such notes issued in substitution therefor pursuant to Section 13). The Series A Notes and the Series B Notes shall be substantially in the forms form set out in Schedule 1(a) Exhibits 1-A and Schedule 1(b)1-B, respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A andB; and references to a “Schedule” or an “Exhibit” are, for purposes of unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement, the rules of construction set forth in Section 23.4 shall govern.

Authorization of Notes. The Issuer Company will authorize the issue and sale of (i) $240,000,000 75,000,000 aggregate principal amount of its Guaranteed 2.45% Senior Notes, of which $120,000,000 aggregate principal amount shall be its 4.69% Series A Guaranteed Senior Notes A, due January 10November 16, 2026 2036 (the “Series A Notes”) and (ii) $120,000,000 95,000,000 aggregate principal amount shall be of its 4.792.96% Senior Notes, Series B Guaranteed Senior Notes B, due January 10August 25, 2028 2052 (the “Series B Notes”; ” and, together with the Series A Notes and the Series B Notes are hereinafter referred to collectively as Notes, collectively, (the “Notes”,” such term to include any such notes issued in substitution therefor pursuant to Section 14). The Series A Notes shall be substantially in the form set out in Schedule 1(a) and the Series B Notes shall be substantially in the forms form set out in Schedule 1(a) and Schedule 1(b), respectively. Each series of notes is sometimes referred to herein as a “series”. Certain capitalized and other terms used in this Agreement are defined in Schedule A and, for purposes of this Agreement, the rules of construction set forth in Section 23.4 22.4 shall govern.